McEldrew Young is a Philadelphia-based whistleblower law firm with attorneys representing health care whistleblowers in False Claims Act litigation nationwide.
We represent sales representatives and other health care professionals in some of the largest whistleblower lawsuits in the country.
Our clients report evidence of violations of the False Claims Act including Medicare and Medicaid fraud through a qui tam lawsuit to the Justice Department, Centers for Medicare & Medicaid Services, and other government agencies.
We are ready to help doctors, nurses, pharmacists, sales representatives and other health care professionals report violations of the Anti-Kickback Statute and Stark Law to the U.S. Government.
Fill out the contact form to the right for a free, confidential legal consultation.
Suspect Health Care Fraud? Let’s Report It:
About McEldrew Young, Attorneys-at-Law
Eric L. Young has represented employees from corporate executives to sales representatives in whistleblower matters for over a decade. He currently represents whistleblowers in litigation against Novartis, Pfizer and Teva and has previously represented individuals in other large cases (including a $425 million fine against Cephalon).
James J. McEldrew, III (Jim) is a trial attorney that represents health care professionals in False Claims Act litigation. He served a term as the President of the Philadelphia Trial Lawyers Association and has represented victims of misconduct by health care companies from medical device manufacturers to doctors in hospital for almost thirty years.
Call us at 1-800-590-4116.
Our Anti-Kickback and Stark Law Practice
Our attorneys are currently representing whistleblowers in some of the largest cases of health care fraud in the country, including lawsuits against Novartis, Pfizer and Teva.
We represent the whistleblower in the U.S. Government’s case against Novartis over suspected violations of the Anti-Kickback Statute. The government’s complaint alleges that the pharmaceutical company engaged in sham speaker programs that were actually kickbacks to doctors. For additional information about the case, see the coverage in Bloomberg, the Wall Street Journal and Reuters.
We also represent whistleblowers in non-intervened lawsuits alleging illegal kickbacks, and other violations of the False Claims Act, against Pfizer and Teva. These cases have survived motions to dismiss by the defendants and are presently in discovery.
Do you have evidence of kickbacks paid to a doctor, hospital, pharmacy or other healthcare provider or supplier by a pharmaceutical company, medical device manufacturer, home health agency or other beneficiary of health care referrals?
We Help Report Violations of the Anti-Kickback Statute and Stark Law Because Kickbacks Increase Health Care Costs and Bad Medical Decisions.
As health care fraud grew in the federal government insurance programs, Congress passed and expanded the Anti-Kickback Statute to limit payments for referrals. Referrals increase the cost of services to the government and mean that treatment decisions may not be based on the best interests of the patient.
Congress passed the first Stark Law, commonly referred to as Stark I, in order to address the growing problem in the 1990s of increased health care costs due to self-referrals to physician-owned clinical laboratories. A year later, in Stark II, Congress expanded the law to include referrals to other designated health services. The concern is that the doctor is ordering services because of their ownership interest in the facility and not because of the medical necessity for the patient.
The U.S. Government has made tremendous strides in the past few years in exposing industry kickbacks through the Open Payments Sunshine Act and other efforts to increase transparency about the health care industry. Additionally, the Justice Department, with the help of employees inside these companies, has taken enforcement actions against several major health care companies. However, we expect that pharmaceutical companies, medical device manufacturers and hospitals will find new ways to increase sales revenue that still violate the False Claims Act.
Suspect A Violation of the Anti-Kickback Statute or Stark Law?
Let Us Evaluate Your Evidence.
The Anti-Kickback Statute and Stark Law are simple in theory and complex in practice. There are numerous exceptions to the Stark Law and safe-harbors to the Anti-Kickback Statute. The government also frequently updates the regulations and issues advisory guidelines on permitted practices.
We encourage individuals to discuss the suspected kickback violations with us before internal reporting to their employer or external reporting to CMS and the U.S. Government. It is important to have an attorney review it in order to confirm that the practice does not fall within an exception or safe harbor.